Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Repros Therapeutics has reported that its total revenues decreased 15% to $269,000 for the three-month period ended March 31, 2008 as compared to $318,000 for the same period of 2007 primarily due to lower cash balances.
Subscribe to our email newsletter
Net loss for the three-month period ended March 31, 2008, was $6.7 million or $0.52 per share as compared to a net loss of $3.7 million or $0.31 per share for the same period in 2007.
Research and development expenses, including contracted clinical activities, regulatory affairs and general research expenses increased 104% to $6.2 million for the three-month period ended March 31, 2008 from $3 million for the same period in 2007.